Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
Neurobiology of Aging|November 6, 2016
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyLisa Wang, Michael G Heckman, Jan O Aasly, et al.
Annals of Neurology|November 7, 2025
Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body DiseaseMarios Gavrielatos, Michael G Heckman, Alexandra I Soto-Beasley, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Dopamine pathway and Parkinson's risk variants are associated with levodopa-induced dyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
Neurobiology of Aging|July 26, 2011
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's diseaseManu Sharma, Demetrius M Maraganore, John P A Ioannidis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2024
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced DyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
Nature Genetics|June 21, 2011
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsyGünter U Höglinger, Nadine M Melhem, Dennis W Dickson, et al.
Plos One|September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease researchSelina Wray, Matthew Self, , et al.
JAMA Neurology|September 15, 2025
Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson DiseasePhilip A Starr, Rajat S Shivacharan, Edward Goldberg, et al.
Neurology|July 13, 2012
Large-scale replication and heterogeneity in Parkinson disease genetic lociManu Sharma, John P A Ioannidis, Jan O Aasly, et al.
Pageof 31